Clinical trials

  • NUSINERSEN for Spinal Muscular Atrophy
  • CAPECITABINE for Gastric adenocarcinoma (resectable, stage IB–IIC)
  • REGORAFENIB for Arteriovenous malformations
  • TRABECTEDIN for Metastatic leiomyosarcoma | Locally advanced leiomyosarcoma
  • NIVOLUMAB for Urothelial carcinoma (unresectable or metastatic)
  • BELIMUMAB for Systemic sclerosis-associated interstitial lung disease
  • SACITUZUMAB TIRUMOTECAN for Squamous non-small cell lung cancer
  • BI 764532 for Glioma (DLL3-positive)
  • SOTORASIB for Non-small cell lung cancer (KRAS G12C-mutated)|Advanced non-small cell lung cancer (stage III/IV)
  • bictegravir, lenacapavir for HIV-1 infection
  • GD2IL18CART for Neuroblastoma | Advanced breast cancer | Ewing sarcoma | Osteosarcoma
  • cetrelimab for Metastatic prostate cancer | Prostate cancer metastatic